$VXRT The first time I see something meaningful in MF article. "The key reason for these increases is simple: Because of its powerful delta variant, the coronavirus is very much on the rise again. : If the coronavirus surge continues, it's very possible we'll face an "all hands on deck," situation with vaccines. Perhaps the ones being developed by vaccine-focused biotechs Novavax and Vaxart will be authorized by the FDA. Novavax plans to file for Emergency Use Authorization for its NVX-CoV2373 this quarter, and Vaxart will certainly be on investors' radar due to the oral vaccine it's currently developing -- despite the fact that this program has attracted its share of controversy."
7
6
6 Likes